Clinical Trials for Vorinostat (ZOLINZA)

3 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCMEL1351
10/17/2013
A Phase 2 study of Vorinostat (NSC 701852) in Metastatic Uveal Melanoma
TreatmentECOGHEMS1117
09/10/2013
A Randomized Phase II Study of Azacitidine in Combination with Lenalidomide (NSC-703813) Vs. Azacitidine Alone Vs. Azacitidine in Combination with Vorinostat (NSC-701852) for Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
TreatmentECOGHEMS1203
07/26/2013
A Randomized Phase III Study of Standard Cytarabine plus Daunorubicin (7+3) Therapy or Idarubicin with High Dose Cytarabine (IA) versus IA with Vorinostat (IA+V) in Younger Patients with Previously Untreated Acute Myeloid Leukemia (AML)

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.